Theravance Biopharma has named former Acorda Therapeutics Chief Business Officer Andrew Hindman as Senior VP and Chief Financial Officer. Hindman, who led Acorda's acquisition of Inbrija inhaled L-dopa developer Civitas Therapeutics in 2014, also previously served as President and CEO of Tobira Therapeutics and held executive positions at Onyx Pharmaceuticals and … [Read more...] about Theravance Biopharma appoints Andrew Hindman as Senior VP and CFO
People
TFF Pharmaceuticals raises over $8 million, announces executive appointments
DPI developer TFF Pharmaceuticals said that is has raised $8.17 million through a Series A preferred stock offering and that it will use the funds for R&D. In April 2018, the company announced that it had raised $14 million for development of inhaled drugs, also through a Series A preferred stock offering. In the past year, TFF has received patents in the … [Read more...] about TFF Pharmaceuticals raises over $8 million, announces executive appointments
Nanoform appoints Miguel Cansado as Director of Project Management
Nanonization company Nanoform has named former Hovione Senior Project Manager Miguel Cansado as Director of Project Management. Cansado is the third former Hovione employee to join Nanoform this year, following the appointments of Miguel Calado as Vice Chairman of the Board and Gonçalo Rebelo de Andrade as Chief of Business Operations. Cansado said, “I am very … [Read more...] about Nanoform appoints Miguel Cansado as Director of Project Management
Robert Clarke steps down as Pulmatrix CEO
Robert Clarke is stepping down as CEO of DPI developer Pulmatrix and will be succeeded immediately by current Chief Business Officer Ted Raad, the company said. Clarke, who was appointed CEO in 2012, will stay on through August 14, 2019 as an advisor. Clarke said, "After fifteen years at Pulmatrix growing with the organization from Head of R&D to CSO and … [Read more...] about Robert Clarke steps down as Pulmatrix CEO
Nanoform appoints David Rowe as Head of Manufacturing
Nanoform has announced the appointment of former GSK Particle Size Reduction Lead David Rowe as Head of Manufacturing. In December 2018, the Finnish nanotechnology company announced the construction of a new GMP manufacturing facility in Helsinki. Rowe is the latest in a series of new hires by Nanoform over the past few months, including former Hovione Business … [Read more...] about Nanoform appoints David Rowe as Head of Manufacturing
Neurelis adds senior management personnel in anticipation of Valtoco nasal spray launch
Neurelis, which submitted an NDA for its Valtoco diazepam nasal spray in September 2018, has announced the appointments of a number of senior management personnel in anticipation of a launch. The appointments announced took place from late 2017 to 2019. The hires include George Stuart as Chief Financial Officer, Chuck DeWildt as Chief Commercial Officer, Adrian … [Read more...] about Neurelis adds senior management personnel in anticipation of Valtoco nasal spray launch
Nanoform names Miguel Calado as Vice Chairman of the Board
Finnish particle engineering company Nanoform has named former Hovione executive Miguel Calado as Vice Chairman of the Board. In addition to having served as CFO and VP of Finance of Hovione, Calado has also been CFO of PepsiCo International and President of International Operations at Dean Foods. Earlier this year, Nanoform named former Hovione Business … [Read more...] about Nanoform names Miguel Calado as Vice Chairman of the Board
Synspira Therapeutics appoints Robert Gallotto as President and CEO
Synspira Therapeutics, which is developing an inhaled therapy for cystic fibrosis, has announced the appointment of Robert Gallotto as President and CEO. Gallotto was most recently President and co-founder of Alcresta Therapeutics. He previously co-founded Allena Pharmaceuticals and served in executive positions at Alnara Pharmaceuticals, Altus Pharmaceuticals, and … [Read more...] about Synspira Therapeutics appoints Robert Gallotto as President and CEO
Iconovo appoints Roger Lassing as VP Business Development
Swedish DPI company Iconovo has announced the appointment of Roger Lassing as Vice President Business Development. Lassing, who was most recently Senior Manager of Global Business Development at LEO Pharma, has previously held executive positions at Takeda, Nycomed, and AstraZeneca, where he was Global Brand Manager for Symbicort. Over the past few years, Iconovo … [Read more...] about Iconovo appoints Roger Lassing as VP Business Development
Impel NeuroPharma appoints Jennifer L. Berman as VP of Marketing
Intranasal drug developer Impel NeuroPharma has announced the appointment of Jennifer L. Berman VP of Marketing. Berman was most recently Worldwide Brand Director at Novartis Pharmaceuticals. In December 2018, Impel announced that it had raised $67.5 million in a Series D financing round for continued development of intranasal products based on its Precision … [Read more...] about Impel NeuroPharma appoints Jennifer L. Berman as VP of Marketing